Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe

Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe

 

RELEASE DATE
28-Dec-2006
REGION
Europe
Research Code: B796-01-00-00-00
SKU: HC01173-EU-MR_05270
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC01173-EU-MR_05270
$4,950.00
DownloadLink
ENQUIRE NOW

Description

This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.

Table of Contents

Methodology Of Research

  • The "12 Step" Market Engineering Research Methodology and Process

Overview

  • Market Analysis
  • Scope and Objectives
  • Pricing and Reimbursement
  • The Biosimilars Opportunity

Pharmaceutical Cost-containment Measures

  • Reference Pricing
  • Parallel Trade
  • Generic Substitution
  • Patient Co-payments and Reimbursement

Political/Legal/Regulatory Issues

  • Impact of EU Accession
  • The Roche/Bolar Provision
  • Data Exclusivity and Marketing Authorisation Applications

Group I

Group II

  • Denmark
  • Germany
  • The Netherlands
  • The United Kingdom

Group III

  • Austria
  • Belgium
  • France
  • Italy
  • Portugal
  • Spain
Related Research
This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number B796-01-00-00-00
Is Prebook No